SAN DIEGO — You don’t see a whole lot of senior citizens cruising around San Diego on inline skates, let alone setting racing records in national competitions. 78-year-old Roger Olson was making ...

A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ...

MitraClip, a catheter-delivered device, has been approved by the US Food and Drug Administration (FDA) for treatment of patients with significant symptomatic degenerative mitral regurgitation who are ...

CHICAGO -- Emerging real-world data supported benefits of MitraClip therapy in patients with secondary mitral regurgitation (MR) who didn't fit the COAPT profile, the EXPAND study showed. MR was often ...

January 6, 2012 (London, United Kingdom) — Results from the high-surgical-risk arm of the EVEREST II trial with the percutaneous MitraClip (Abbott) device, suggesting reduced mitral regurgitation and ...

Global health care major Abbott Laboratories ABT recently presented one-year positive outcomes from the study of the MitraClip system in transcatheter mitral valve repair (TMVR) procedures in the U.S.

Please provide your email address to receive an email when new articles are posted on . SAN DIEGO — Patients with HF with moderate to severe or severe functional mitral regurgitation who underwent ...

The Ministry of Health Labour and Welfare ("MHLW") in Japan granted national reimbursement to Abbott 's ABT MitraClip therapy. The move is likely to improve the company's Structural Heart business.

Technology in medicine changes so quickly. As doctors put those new techniques to use, some stand out as things that will soon become the norm. In this month’s MedWatch, we learn about a heart ...

Surgical repair decreased MR more than MitraClip ®. In 12-month follow-up, 20% of MitraClip patients required surgery for mitral dysfunction versus 2% in surgical patients. Both groups had ...